Ancient Material Promises To Solve Drug Delivery “Pain”
Vaxess is a venture capital and Gates Foundation-backed company that is developing vaccine patches. Their mission is to significantly increase …
Premium Articles
What to Consider Before Launching a Biotech Startup in 2022?
Luciano Santollani is currently working towards his PhD at MIT developing novel cancer therapeutics, and is also working as a …
Current Trends in Nanomedicine: Notable FDA Approvals and Clinical Trials to Follow
Nanomedicines, as it goes from the name, are nanotechnology-based drugs, used for the treatment, diagnosis or prevention of various diseases. …
Toronto’s Blossoming AI-driven Drug Discovery Scene
Canada has established itself as a rapidly growing global hub for artificial intelligence (AI) innovation and commercialization. This roots deep …
3D Printed Muscle Tissues for Drug Discovery With Mantarray™ Platform by Curi Bio
Curi Bio, a developer of human stem cell-based platforms for drug discovery, announced the commercial launch of the Mantarray™ platform …
Transformational EGFR Drug Discovery
Lung cancer accounted for 18% of deaths caused by cancer in 2020, making it the leading cause of cancer mortality …
Valo Therapeutics Aims to Improve Personalized Immunotherapy With a New Tech
Valo Therapeutics Oy (ValoTx), the developer of antigen-coated oncolytic viruses and vaccine vectors as therapeutic vaccines against cancer and infectious …
Cyclica's Chemical Probes for DCAF1
Cyclica is designing chemical probes for DCAF1, a potentially novel target for protein degradation, with proprietary technology MatchMaker DCAF1 was …
AI-powered Cryo-EM Attracts Big Bucks And Promises To Disrupt Structural Biology
Shuimu BioSciences, a biotech start-up working towards the implementation of cryo-EM into drug discovery, got an investment from the internet …
Applying AI and HPC to Drug Design: a Survey of R&D Work
The motivation for this report In 2018, while at Supercomputing in Dallas I had a couple key encounters that profoundly …
Endogena Therapeutics Doses First Patient With Novel Treatment For All Retinitis Pigmentosa Types
Endogena Therapeutics, a biotech company that focuses on the first-in-class endogenous regenerative medicines, just announced treating the first patient with …
How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange
This is a sponsored case study republished from ScienceExchange.com Over the past decade, the biopharmaceutical industry has undergone a massive …